Edition:
United Kingdom

Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

1,681.30INR
10:10am GMT
Change (% chg)

Rs-15.80 (-0.93%)
Prev Close
Rs1,697.10
Open
Rs1,686.90
Day's High
Rs1,699.80
Day's Low
Rs1,621.95
Volume
26,419
Avg. Vol
32,814
52-wk High
Rs1,960.00
52-wk Low
Rs919.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun 1,614.37 2.560
FY 2018 Mar '18 1,507.27 1.287
Dec 1,285.39 -4.141
Sep 1,642.58 10.954
Jun 1,284.66 2.320
FY 2017 Mar '17 1,168.86 -3.826
Dec 1,515.02 6.484
Sep 1,394.06 0.315
Jun 1,408.65 5.041
FY 2016 Mar '16 1,588.20 0.223
Dec 1,445.82 3.470
Sep 1,283.53 -2.680
Jun 1,319.77 1.087
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 120.54 30.86 33.64
P/E High - Last 5 Yrs. 548.94 40.52 45.61
P/E Low - Last 5 Yrs. 95.66 23.24 23.70
Beta 0.50 0.89 0.88
Price to Sales (TTM) 4.49 4.02 5.95
Price to Book (MRQ) -- 4.77 4.89
Price to Tangible Book (MRQ) -- 5.60 6.50
Price to Cash Flow (TTM) 67.54 22.52 22.90
% Owned Institutions -- 1.13 2.15

Dividends

  Company industry sector
Dividend Yield -- 1.59 1.51
Dividend Yield - 5 Year Avg -- 1.59 1.52
Dividend 5 Year Growth Rate -- 4.42 5.41
Payout Ratio(TTM) 0.00 46.15 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -8.80 2.23 8.08
Sales (TTM) vs TTM 1 Yr. Ago -7.71 4.64 5.80
Sales - 5 Yr. Growth Rate 0.30 9.65 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -53.97 19.34 23.27
EPS (TTM) vs TTM 1 Yr. Ago 30.10 -- --
EPS - 5 Yr. Growth Rate 4.34 9.95 10.88
Capital Spending - 5 Yr. Growth Rate -32.37 15.07 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.27
Current Ratio (MRQ) -- 2.99 3.07
LT Debt to Equity (MRQ) -- 10.29 13.15
Total Debt to Equity (MRQ) -- 14.52 17.74
Interest Coverage (TTM) -- 41.32 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 66.88 55.21 54.86
Gross Margin - 5 Yr. Avg. 58.94 52.32 52.38
EBITD Margin (TTM) 3.71 -- --
EBITD - 5 Yr. Avg -1.89 18.47 10.90
Operating Margin (TTM) 0.79 14.21 3.24
Operating Margin - 5 Yr. Avg. -3.91 14.35 6.22
Pre-Tax Margin (TTM) 5.09 14.75 4.31
Pre-Tax Margin - 5 Yr. Avg. -2.10 14.80 6.66
Net Profit Margin (TTM) 3.72 10.97 0.58
Net Profit Margin - 5 Yr. Avg. -3.27 11.07 2.90
Effective Tax Rate (TTM) 26.88 23.35 23.26
Effective Tax Rate - 5 Yr. Avg. -- 23.63 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) 4,631,859 905,167,937 803,310,882
Net Income/Employee (TTM) 172,405 106,519,700 94,478,474
Receivable Turnover (TTM) -- 5.61 5.78
Inventory Turnover (TTM) -- 2.61 3.71
Asset Turnover (TTM) -- 0.94 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.33 10.86
Return on Assets - 5 Yr. Avg. -4.28 12.57 11.96
Return on Investment (TTM) -- 14.72 14.22
Return on Investment - 5 Yr. Avg. -10.35 16.38 15.54
Return on Equity (TTM) -- 16.27 15.99
Return on Equity - 5 Yr. Avg. -10.64 17.46 16.82
  1 Year 3 Year 5 Year
Sales % -4.29 4.42 0.30
EPS (TTM) % 364.77 -- 4.34
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Astrazeneca Pharma India Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.27 1.86 99 22
13 Week -4.17 -5.54 99 33
26 Week 0.58 -6.08 99 27
52 Week 0.44 -11.26 99 13
YTD 2.48 -14.23 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.69%
# of Holders: 4
Total Shares Held: 1,421,259
3 Mo. Net Change: -69,305
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.